Aromatase inhibitors

511 Pill - yellow round

Pill with imprint 511 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Sun Pharmaceutical Industries Inc.

Letrozole is used in the treatment of Breast Cancer, Metastatic; Breast Cancer, Adjuvant; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Letrozole (Letrozole [ let-roe-zol ])-511-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-511-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-511-2.5 mg-Yellow-Round

Letrozole
Generic Name: letrozole [ let-roe-zol ]
Imprint: 511
Strength: 2.5 mg
Color: Yellow
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Aromatase inhibitors Hormones / antineoplastics
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 62756-0511 (Discontinued)
Inactive Ingredients: Lactose monohydrate, Microcrystalline cellulose, Corn starch, Povidone k30, Sodium starch glycolate type A potato, Silicon dioxide, Magnesium stearate, Hypromelloses, Ferric oxide yellow, Titanium dioxide, Polyethylene glycol, Magnesium silicate,
Latest News
Related Drugs